Lagevrio (Molnupiravir, emorivir, Molxvir, Molnulup) is an oral antiviral that inhibits the replication of multiple RNAs viruses, including SARS-CoV-2, the causative agent of COVID-19.Read more...
Lyme Disease Vaccine (VLA15)
Valneva Lyme Disease vaccine VLA15 targets the outer surface protein A (OspA) of Borrelia.Read more...
Lyme Disease Vaccines
Lyme Disease was first described in 1977 as "Lyme arthritis" after a cluster of cases was reported in Old Lyme, Connecticut.Read more...
Lyme PrEP Antibody Treatment
Lyme PrEP Antibody Treatment delivers a single anti-Lyme antibody directly to a person.Read more...
